Your shopping cart is currently empty

PD-L1/HDAC3-IN-1 (PH3) is a dual inhibitor of PD-L1 and HDAC3, exhibiting IC50 values of 89.4 nM for PD-1/PD-L1 and 107 nM for HDAC3. It induces apoptosis and arrests the cell cycle in the G0/G1 phase. PD-L1/HDAC3-IN-1 demonstrates anticancer activity both in vitro and in vivo.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PD-L1/HDAC3-IN-1 (PH3) is a dual inhibitor of PD-L1 and HDAC3, exhibiting IC50 values of 89.4 nM for PD-1/PD-L1 and 107 nM for HDAC3. It induces apoptosis and arrests the cell cycle in the G0/G1 phase. PD-L1/HDAC3-IN-1 demonstrates anticancer activity both in vitro and in vivo. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.